Bayer AG (ADR)

General ticker "BAYRY" information:

  • Sector: Health Care
  • Industry: Drug Manufacturers - General
  • Capitalization: $42.3B (TTM average)

Bayer AG (ADR) follows the US Stock Market performance with the rate: 40.1%.

Estimated limits based on current volatility of 0.9%: low 13.95$, high 14.20$

Factors to consider:

  • Company pays dividends (annually): last record date 2026-04-28, amount 0.03$ (Y0.21%)
  • Price in estimated range
  • Earnings for 6 months up through Q2 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2025-12-31 to 2027-12-31

  • 2025-12-31 to 2026-12-31 estimated range: [8.95$, 14.66$]
  • 2026-12-31 to 2027-12-31 estimated range: [10.38$, 16.49$]

Financial Metrics affecting the BAYRY estimates:

  • Positive: with PPE of 7.9 at the end of fiscal year the price was neutral
  • Positive: 11.37 < Operating cash flow per share per price, % of 12.37
  • Positive: 11.29 < Operating profit margin, % of 15.26
  • Positive: Industry inventory ratio change (median), % of 0.50 <= 1.15
  • Positive: 14.78 < Industry operating profit margin (median), % of 24.67
  • Positive: Industry earnings per price (median), % of 6.62 > 6.58
  • Positive: Interest expense per share per price, % of 4.66 <= 10.35
  • Positive: 5.56 < Industry operating cash flow per share per price (median), % of 5.61
  • Positive: -7.72 < Return on assets ratio (scaled to [-100,100]) of -3.05

Similar symbols

Short-term BAYRY quotes

Long-term BAYRY plot with estimates

Financial data

YTD 2024-12-31 2025-12-31
Operating Revenue €46,606.00MM €43,776.28MM
Operating Expenses €43,279.00MM €37,096.73MM
Operating Income €3,327.00MM €6,679.54MM
Non-Operating Income €-5,661.00MM €-9,685.05MM
Interest Expense €2,358.00MM €1,654.04MM
R&D Expense €6,209.00MM €5,541.31MM
Income(Loss) €-2,334.00MM €-3,005.51MM
Taxes €212.00MM €447.61MM
Net Income(Loss)* €-2,552.00MM €-3,477.13MM
Stockholders Equity €31,908.00MM €25,935.96MM
Inventory €13,403.00MM €12,372.73MM
Assets €110,850.00MM €110,558.93MM
Operating Cash Flow €7,368.00MM €4,390.59MM
Capital expenditure €2,778.00MM €2,388.84MM
Investing Cash Flow €164.00MM €-1,545.50MM
Financing Cash Flow €-7,178.00MM €-2,099.72MM
Earnings Per Share** €-0.65 €-0.88
Ordinary share to ADR 1.00x 1.00x

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.